Abstract
From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.
Original language | English (US) |
---|---|
Pages (from-to) | 969-973 |
Number of pages | 5 |
Journal | Clinical Infectious Diseases |
Volume | 61 |
Issue number | 6 |
DOIs | |
State | Published - Jun 8 2015 |
Keywords
- Ebola
- investigational therapies
- trials
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases